Use of the cheap and readily available 99m-tc as a radioisotope to perform tumour-specific metabolic diagnosis in patients with cancer.
Production of recombinant allergens and secretory iga in the milk of transgenic rabbits. These compounds will be used for clinical trials to assess their efficiency as a treatment for allergies.
Efficient control strategies against phytoplasma vectoring psyllids will be established by the help of molecular markers to study their life cycle, by determining the transmission parameters and by developing disturbation strategies.
The goal of the project is to develop improved disease therapies based on a new generation of therapeutic proteins
An innovative technology for robust high-productivity processes will be established and scaled-up. A compendium of the knowledge gathered regarding mixed substrate cultivation will be made available.
To develop a polymer scaffold that induces chondrogenesis of bone marrow derived mesenchymal cells and enables the generation of hyaline cartilage when implanted in cartilage defects in combination with standard microfracture treatment.
Development of a rapid and easy-to-use anti-epo affinity tool for purifying epo from urine and blood which facilitates characterisation of epo isoforms appearing during pathological conditions and differentiation of endogenous and recombinant epo during therapy and after illegal doping.
Patented drug formulations of a phthalocyanine photosensitiser based on microfludised lipids in a gel are being developed for photodynamic therapy of tumours together with non-coherent and coherent light sources suitable for the market.
Two european r&d-oriented companies have decided to collaborate in r&d to promote disruptive change in lung lobectomy surgery; broad-scale conversion from open surgery to video assisted thoracic surgery (vats). The project will result in the first ever simulator for vats-lobectomy.
ALZHEIMER Transdermal Therapeutic Systems